The blood-brain barrier protects the brain from harmful substances, but it also prevents many medicines from reaching their ...
A landmark genome-wide study of more than 2.5 million adults has identified 26 genomic regions linked to fibromyalgia, ...
Researchers at Texas A&M have developed AI-driven platforms to help scientists navigate the bottlenecks of tuberculosis drug ...
A blood-based biomarker measuring amyloid beta protein misfolding has demonstrated superior predictive accuracy for ...
Understanding where proteins are expressed throughout the body is critical for selecting better drug targets. Here's how a ...
A new study published in Science identifies a specialised dendritic cell subset as the cellular architects behind tertiary ...
How can human biology data improve target selection? Learn how one discovery programme identified a potential new treatment ...
Insilico Medicine has unveiled a benchmarking platform designed to assess whether AI models can perform genuine drug discovery tasks, using decontaminated real-world datasets and proprietary validated ...
A new review examines how physical, bioengineered and biomimetic delivery platforms that bypass conventional endocytic uptake ...
Researchers have developed Fullscope-seq, a long-read spatial transcriptomics platform that maps alternative transcript isoforms within intact tissues at single-cell resolution - opening new ...
An experimental oral antiviral has demonstrated the ability to prevent both airborne and contact-based transmission of a ...
As oligonucleotide therapeutics rapidly advance, their safety profile presents challenges unlike any other drug modality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results